2-propanol has been researched along with 2019 Novel Coronavirus Disease in 35 studies
2-Propanol: An isomer of 1-PROPANOL. It is a colorless liquid having disinfectant properties. It is used in the manufacture of acetone and its derivatives and as a solvent. Topically, it is used as an antiseptic.
propan-2-ol : A secondary alcohol that is propane in which one of the hydrogens attached to the central carbon is substituted by a hydroxy group.
Excerpt | Relevance | Reference |
---|---|---|
"The advent of coronavirus disease 2019 (COVID-19) has further enhanced their use." | 2.66 | Efficacies of the original and modified World Health Organization-recommended hand-rub formulations. ( Kampf, G; Steinmann, J; Suchomel, M, 2020) |
"Hyponatremia is the most common electrolyte disorder in COVID 19 infection." | 1.91 | Acute angle-closure glaucoma concurrent with COVID 19 infection; case report. ( Alagöz, G; Çakır, B; Özkan Aksoy, N; Özmen, S, 2023) |
"Two cases with a recent history of coronavirus disease 2019 (COVID-19) presented with a complaint of decreased vision." | 1.91 | Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection. ( Evereklioglu, C; Gulmez Sevim, D; Sener, H, 2023) |
"Systemic viral infections, including coronavirus disease 2019, may be the triggering event in several cases." | 1.72 | Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update. ( Altan, Ç; Tuğal-Tutkun, İ, 2022) |
"Patients with alcohol use disorders, on disulfiram, might experience disulfiram ethanol like reactions with alcohol-based sanitizers." | 1.62 | Disulfiram Ethanol Reaction with Alcohol-Based Hand Sanitizer: An Exploratory Study. ( Balhara, YPS; Basu, D; Bn, S; Ghosh, A; Mahintamani, T; Mattoo, SK; Mishra, E; Roub, FE; Sharma, B, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 35 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fadaei, A | 1 |
Duane, B | 1 |
Pilling, J | 1 |
Saget, S | 1 |
Ashley, P | 1 |
Pinhas, AR | 1 |
Lyne, A | 1 |
Majorani, C | 1 |
Leoni, C | 1 |
Micheli, L | 1 |
Cancelliere, R | 1 |
Famele, M | 1 |
Lavalle, R | 1 |
Ferranti, C | 1 |
Palleschi, L | 1 |
Fava, L | 1 |
Draisci, R | 1 |
D'Ilio, S | 1 |
Tadesse, TA | 2 |
Antheneh, A | 2 |
Teklu, A | 2 |
Teshome, A | 2 |
Alemayehu, B | 2 |
Belayneh, A | 2 |
Abate, D | 2 |
Abiye, AA | 2 |
Rafizadeh, A | 1 |
Kolahi, AA | 1 |
Shariati, S | 1 |
Zamani, N | 1 |
Roberts, DM | 1 |
Hassanian-Moghaddam, H | 1 |
Nisbar, ND | 1 |
Jamal Khair, SK | 1 |
Bujang, NB | 1 |
Mohd Yusop, AY | 1 |
Halamicek, R | 1 |
Wiesmann, C | 1 |
Kröner, R | 1 |
Eber, M | 1 |
Bogdan, C | 1 |
Schubert, DW | 1 |
Opatz, T | 1 |
Senn-Bilfinger, J | 1 |
Richert, C | 1 |
Suchomel, M | 2 |
Eggers, M | 1 |
Maier, S | 1 |
Kramer, A | 1 |
Dancer, SJ | 1 |
Pittet, D | 1 |
Welch, JL | 1 |
Xiang, J | 1 |
Mackin, SR | 1 |
Perlman, S | 1 |
Thorne, P | 1 |
O'Shaughnessy, P | 1 |
Strzelecki, B | 1 |
Aubin, P | 1 |
Ortiz-Hernandez, M | 1 |
Stapleton, JT | 1 |
Steinmann, J | 1 |
Kampf, G | 1 |
McCulley, L | 1 |
Cheng, C | 1 |
Mentari, E | 1 |
Diak, IL | 1 |
Michele, T | 1 |
Jahromi, R | 1 |
Mogharab, V | 1 |
Jahromi, H | 1 |
Avazpour, A | 1 |
Tasar, R | 1 |
Wiegand, C | 1 |
Elsner, P | 1 |
Babić, Ž | 1 |
Turk, R | 1 |
Macan, J | 1 |
Ghosh, A | 1 |
Mahintamani, T | 1 |
Balhara, YPS | 1 |
Roub, FE | 1 |
Basu, D | 1 |
Bn, S | 1 |
Mattoo, SK | 1 |
Mishra, E | 1 |
Sharma, B | 1 |
Tan, SW | 1 |
Oh, CC | 1 |
Grillet, AM | 1 |
Nemer, MB | 1 |
Storch, S | 1 |
Sanchez, AL | 1 |
Piekos, ES | 1 |
Leonard, J | 1 |
Hurwitz, I | 1 |
Perkins, DJ | 1 |
Martin, GC | 1 |
Le Roux, G | 1 |
Guindolet, D | 1 |
Boulanger, E | 1 |
Hasle, D | 1 |
Morin, E | 1 |
Vodovar, D | 1 |
Vignal, C | 1 |
Gabison, E | 1 |
Descatha, A | 1 |
Hirose, R | 1 |
Bandou, R | 1 |
Ikegaya, H | 1 |
Watanabe, N | 1 |
Yoshida, T | 1 |
Daidoji, T | 1 |
Naito, Y | 1 |
Itoh, Y | 1 |
Nakaya, T | 1 |
Khade, S | 1 |
Gite, S | 1 |
Thepade, SD | 1 |
Pradhan, B | 1 |
Alamri, A | 1 |
Patnaik, G | 1 |
Arunkumar, WV | 1 |
Lagvankar, M | 1 |
Özmen, S | 1 |
Özkan Aksoy, N | 1 |
Çakır, B | 1 |
Alagöz, G | 1 |
Yüksel, M | 1 |
Özdemir, HB | 1 |
Özdek, Ş | 1 |
Gürelik, G | 1 |
Gaur, S | 1 |
Sindhu, N | 1 |
Singh, DV | 2 |
Bhattacharya, M | 1 |
Sharma, A | 1 |
Shinde, D | 1 |
Arora, A | 1 |
Niedzwiecka, E | 1 |
Cantó San Miguel, MP | 1 |
Gonzalez Herrera, M | 1 |
Sánchez Rodriguez-Acosta, I | 1 |
Altan, C | 2 |
Basarir, B | 1 |
Bayraktar, S | 1 |
Tugal-Tutkun, I | 2 |
Cam, F | 1 |
Celiker, H | 1 |
Lončarić, K | 1 |
Tadić, R | 1 |
Radmilović, M | 1 |
Vatavuk, Z | 1 |
Comba, OB | 1 |
Soydan, A | 1 |
Kaymaz, A | 1 |
Gulmez Sevim, D | 1 |
Sener, H | 1 |
Evereklioglu, C | 1 |
Reddy, PRR | 1 |
Baharani, A | 1 |
3 reviews available for 2-propanol and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants.
Topics: 2-Propanol; Animals; Coronavirus, Canine; COVID-19; Disinfectants; Disinfection; Ethanol; Formaldehy | 2021 |
Efficacies of the original and modified World Health Organization-recommended hand-rub formulations.
Topics: 2-Propanol; Anti-Infective Agents, Local; Betacoronavirus; Coronavirus Infections; COVID-19; Disinfe | 2020 |
How irritant are n-propanol and isopropanol? - A systematic review.
Topics: 1-Propanol; 2-Propanol; Anti-Infective Agents, Local; COVID-19; Dermatitis, Irritant; Hand Disinfect | 2021 |
32 other studies available for 2-propanol and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Hand hygiene with hand sanitizer versus handwashing: what are the planetary health consequences?
Topics: 2-Propanol; COVID-19; Ethanol; Hand Disinfection; Hand Hygiene; Hand Sanitizers; Humans; Pandemics; | 2022 |
Monitoring of alcohol-based hand rubs in SARS-CoV-2 prevention by HS-GC/MS and electrochemical biosensor: A survey of commercial samples.
Topics: 2-Propanol; Biosensing Techniques; COVID-19; Ethanol; Humans; SARS-CoV-2 | 2022 |
COVID-19 Vaccine Hesitancy and its Reasons in Addis Ababa, Ethiopia: A Cross-Sectional Study.
Topics: 2-Propanol; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Drug-Related Side Effects and Adve | 2022 |
COVID-19 Vaccine Hesitancy and its Reasons in Addis Ababa, Ethiopia: A Cross-Sectional Study.
Topics: 2-Propanol; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Drug-Related Side Effects and Adve | 2022 |
COVID-19 Vaccine Hesitancy and its Reasons in Addis Ababa, Ethiopia: A Cross-Sectional Study.
Topics: 2-Propanol; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Drug-Related Side Effects and Adve | 2022 |
COVID-19 Vaccine Hesitancy and its Reasons in Addis Ababa, Ethiopia: A Cross-Sectional Study.
Topics: 2-Propanol; COVID-19; COVID-19 Vaccines; Cross-Sectional Studies; Drug-Related Side Effects and Adve | 2022 |
The danger of the toxicity and inefficacy of alcohol-based hand rubs in Iran during COVID-19: a cross-sectional study.
Topics: 2-Propanol; Adult; COVID-19; Cross-Sectional Studies; Ethanol; Hand Disinfection; Humans; Iran; Meth | 2023 |
Determination of ethanol, isopropyl alcohol and methanol in alcohol-based hand sanitiser to ensure product quality, safety and efficacy.
Topics: 2-Propanol; COVID-19; Ethanol; Hand Sanitizers; Humans; Methanol | 2023 |
Influence of different treatment conditions on the filtration performance of conventional electret melt blown non-woven and novel nano FFP2 masks.
Topics: 2-Propanol; Cocaine; COVID-19; Filtration; Humans; SARS-CoV-2 | 2023 |
Thoughts on What Chemists Can Contribute to Fighting SARS-CoV-2 - A Short Note on Hand Sanitizers, Drug Candidates and Outreach.
Topics: 2-Propanol; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; DNA Replication; DN | 2020 |
Evaluation of World Health Organization-Recommended Hand Hygiene Formulations.
Topics: 2-Propanol; Betacoronavirus; Coronavirus Infections; COVID-19; Ethanol; Europe; Hand; Hand Hygiene; | 2020 |
Inactivation of Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) and Diverse RNA and DNA Viruses on Three-Dimensionally Printed Surgical Mask Materials.
Topics: 2-Propanol; COVID-19; Decontamination; Disinfectants; Disinfection; DNA, Viral; Healthy Volunteers; | 2021 |
Alcohol-based hand sanitizer exposures and effects on young children in the U.S. during the COVID-19 pandemic.
Topics: 2-Propanol; Child, Preschool; COVID-19; Ethanol; Hand Sanitizers; Humans; Infant; Infant, Newborn; M | 2021 |
Synergistic effects of anionic surfactants on coronavirus (SARS-CoV-2) virucidal efficiency of sanitizing fluids to fight COVID-19.
Topics: 2-Propanol; A549 Cells; Antiviral Agents; Benzenesulfonates; Betacoronavirus; Coronavirus Infections | 2020 |
Toxicological aspects of increased use of surface and hand disinfectants in Croatia during the COVID-19 pandemic: a preliminary report.
Topics: 2-Propanol; Adolescent; Adult; Aged; Aged, 80 and over; Betacoronavirus; Child; Child, Preschool; Co | 2020 |
Disulfiram Ethanol Reaction with Alcohol-Based Hand Sanitizer: An Exploratory Study.
Topics: 2-Propanol; Adult; Alcohol Deterrents; Alcoholism; COVID-19; Cross-Sectional Studies; Disulfiram; Dr | 2021 |
Contact Dermatitis from Hand Hygiene Practices in the COVID-19 Pandemic.
Topics: 1-Propanol; 2-Propanol; Anti-Infective Agents, Local; COVID-19; Dermatitis, Allergic Contact; Dermat | 2020 |
COVID-19 global pandemic planning: Performance and electret charge of N95 respirators after recommended decontamination methods.
Topics: 2-Propanol; COVID-19; Decontamination; Detergents; Humans; Hydrogen Peroxide; N95 Respirators; SARS- | 2021 |
Pediatric Eye Injuries by Hydroalcoholic Gel in the Context of the Coronavirus Disease 2019 Pandemic.
Topics: 2-Propanol; Adolescent; Age Factors; Child; Child, Preschool; COVID-19; Ethanol; Eye Injuries; Femal | 2021 |
Disinfectant effectiveness against SARS-CoV-2 and influenza viruses present on human skin: model-based evaluation.
Topics: 2-Propanol; Anti-Infective Agents, Local; Benzalkonium Compounds; Chlorhexidine; COVID-19; Disinfect | 2021 |
Detection of Iris Presentation Attacks Using Feature Fusion of Thepade's Sorted Block Truncation Coding with Gray-Level Co-Occurrence Matrix Features.
Topics: Bayes Theorem; Biometry; COVID-19; Humans; Iris; SARS-CoV-2; Support Vector Machine | 2021 |
Bilateral Acute Depigmentation of Iris (BADI) Post COVID Infection following Systemic Moxifloxacin Therapy.
Topics: Adult; Aged; COVID-19; Female; Humans; Iris; Iris Diseases; Moxifloxacin; RNA, Viral; SARS-CoV-2 | 2023 |
Acute angle-closure glaucoma concurrent with COVID 19 infection; case report.
Topics: Acute Disease; COVID-19; Glaucoma, Angle-Closure; Humans; Hyponatremia; Intraocular Pressure; Iris; | 2023 |
Bilateral acute Iris transillumination after COVID-19 pneumonia.
Topics: Aged; COVID-19; Humans; Iris; Iris Diseases; Male; Moxifloxacin; Transillumination | 2023 |
COVID-19-related bilateral acute de-pigmentation of iris with ocular hypertension.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; COVID-19; Glaucoma; Humans; Iris; Male; Ocular Hyperte | 2022 |
Commentary: COVID-19-related bilateral acute depigmentation of iris with ocular hypertension.
Topics: COVID-19; Humans; Iris; Iris Diseases; Ocular Hypertension | 2022 |
Bilateral Acute Depigmentation of the Iris (BADI) following Covid-19 Infection.
Topics: COVID-19; Female; Humans; Iris; Iris Diseases; Middle Aged; Pigmentation Disorders; SARS-CoV-2 | 2023 |
Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection.
Topics: COVID-19; Humans; Iris; Iris Diseases; Retrospective Studies; Transillumination | 2023 |
Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update.
Topics: COVID-19; Fluoroquinolones; Humans; Iris; Iris Diseases; Transillumination | 2022 |
Bilateral acute iris transillumination syndrome after SARS-CoV-2 infection: A case report.
Topics: COVID-19; Humans; Iris; Iris Diseases; SARS-CoV-2; Syndrome; Transillumination | 2023 |
Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
Topics: COVID-19; Glaucoma; Humans; Iris; Iris Diseases; Moxifloxacin; Syndrome; Transillumination | 2023 |
SARS-CoV-2 virus-induced bilateral acute iris transillumination syndrome: The first case series in literature.
Topics: COVID-19; Humans; Iris; SARS-CoV-2; Transillumination | 2023 |
Bilateral acute depigmentation of the iris determined in two cases after COVID-19 infection.
Topics: COVID-19; Female; Glaucoma; Humans; Iris; Iris Diseases; Rare Diseases | 2023 |
Bilateral Acute Iris Transillumination and Elevated Intraocular Pressure After COVID-19 Infection.
Topics: COVID-19; Glaucoma; Humans; Intraocular Pressure; Iris; Iris Diseases; Transillumination | 2023 |
Comments on: Retinal vein occlusion in COVID-19: A novel entity.
Topics: COVID-19; Humans; Iris; Lens Implantation, Intraocular; Retinal Vein Occlusion; SARS-CoV-2 | 2021 |